Health News - TOKYO (REUTERS) - A study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's Covid-19 vaccine. The study of 5,893 participants between May and November last year showed that 22.4 per cent. Read more at www.tnp.sg
WASHINGTON, Feb 5 The director of the US Centres for Disease Control and Prevention (CDC) signed off on the US Food and Drug Administration’s full approval of Moderna Inc’s Covid-19 vaccine in those aged 18 and over, the agency said yesterday. The vaccine has been in use under the US Food.
A study in monkeys pitting the current Moderna Inc Covid-19 booster against an Omicron-specific booster showed no significant differences in protection, suggesting an Omicron-specific booster may not be needed, US government researchers reported on Friday.
CHICAGO, Feb 5 A study in monkeys pitting the current Moderna Inc Covid-19 booster against an Omicron-specific booster showed no significant differences in protection, suggesting an Omicron-specific booster may not be needed, US government researchers reported yesterday. The study involved.